Using treated fabric strips to prevent malaria transmission outdoors
Spatial repellents to reduce the outdoor transmission of malaria
This study is looking at special fabric strips that help keep mosquitoes away to see if they can reduce malaria bites for people working outdoors, like forest rangers, in places like Thailand and Cambodia.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10950844 on NIH RePORTER |
What this research studies
This research investigates the effectiveness of transfluthrin-treated hessian fabric strips (TTHFS) in reducing mosquito bites that transmit malaria in outdoor settings. The project involves analyzing data from previous studies in Tanzania and conducting field tests in Thailand and Cambodia to assess how environmental factors like temperature and humidity affect the strips' efficacy. Additionally, it aims to understand how users, such as forest rangers, perceive these fabric strips and identify any barriers to their use. The goal is to develop a viable public health intervention to combat malaria transmission outdoors.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living in or traveling to areas with high outdoor malaria transmission, particularly in Tanzania, Thailand, and Cambodia.
Not a fit: Patients who do not live in malaria-endemic regions or those who are not exposed to outdoor environments where malaria transmission occurs may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a new method for significantly reducing outdoor malaria transmission, improving public health outcomes in affected regions.
How similar studies have performed: Previous studies have shown promise with similar interventions, but this specific approach using TTHFS is relatively novel and aims to build on existing knowledge.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Chen, Ingrid Ting-Ting — University of California, San Francisco
- Study coordinator: Chen, Ingrid Ting-Ting
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.